Journal of Functional Biomaterials · 2022 · 11 citations · 33 references
PharmacyOncologyPharmacologyBiomaterialsChemotherapyDrug DeliveryCancer NanomedicineDrug Delivery BiomaterialsDrug EncapsulationNanocarriers For TherapeuticsNanomedicineNanoparticle FormulationsChitosanChitosan NanocarriersChitosan-based Delivery SystemsCombination TherapyDrug Release Rate CharacterizationDrug Release Rate ControlMicrosphere DeliveryOsteosarcoma Chemotherapy
The purpose of this study is to fabricate different anti-cancer drug-eluted chitosan microspheres for combination therapy of osteosarcoma. In this study, electrospray in combination with ground liquid nitrogen was utilized to manufacture the microspheres. The size of obtained chitosan microspheres was uniform, and the average diameter was 532 μm. The model drug release rate and biodegradation rate of chitosan microspheres could be controlled by the glutaraldehyde vapor crosslinking time. Then the 5-fluorouracil (5-FU), paclitaxel (PTX), and Cis-dichlorodiammine-platinum (CDDP) eluted chitosan microspheres were prepared, and two osteosarcoma cell lines, namely, HOS and MG-63, were selected as cell models for in vitro demonstration. We found the 5-FU microspheres, PTX microspheres, and CDDP microspheres could significantly inhibit the growth and migration of both HOS and MG-63 cells. The apoptosis of both cells treated with 5-FU microspheres, PTX microspheres, and CDDP microspheres was significantly increased compared to the counterparts of control and blank groups. The anti-cancer drug-eluted chitosan microspheres show great potential for the treatment of osteosarcoma.
33
Dual growth factor releasing multi-functional nanofibers for wound healing
Zhiwei Xie, Christian Paras, Hong Weng et al. · Acta Biomaterialia · 2013 · 424 citations · Full text
Natural Sciences, Biomedical Engineering, Materials Science +16
Injectable biomaterials for translational medicine
Huan Zhou, Chunyong Liang, Zi Wei et al. · Materials Today · 2019 · 141 citations · Full text